Showing results (921-930 of 2,691) with videos related to

Sort By:
Pageof 270
The Lancet. Infectious Diseases|April 18, 2015
Are adaptive randomised trials or non-randomised studies the best way to address the Ebola outbreak in west Africa?Simone Lanini, Alimuddin Zumla, John P A Ioannidis, et al.
The Lancet. Infectious Diseases|July 24, 2020
Invasive pneumococcal disease incidence in children and adults in France during the pneumococcal conjugate vaccine era: an interrupted time-series analysis of data from a 17-year national prospective surveillance studyNaïm Ouldali, Emmanuelle Varon, Corinne Levy, et al.
The Lancet. Infectious Diseases|July 21, 2020
Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation studyMaja Jahnmatz, Laura Richert, Nabil Al-Tawil, et al.
The Lancet. Infectious Diseases|March 7, 2015
Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysisMélanie Drolet, Élodie Bénard, Marie-Claude Boily, et al.
The Lancet. Infectious Diseases|June 27, 2020
Advanced imaging tools for childhood tuberculosis: potential applications and research needsSanjay K Jain, Savvas Andronikou, Pierre Goussard, et al.
The Lancet. Infectious Diseases|July 5, 2020
Association between mobility patterns and COVID-19 transmission in the USA: a mathematical modelling studyHamada S Badr, Hongru Du, Maximilian Marshall, et al.
The Lancet. Infectious Diseases|April 13, 2015
Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trialMasashi Mizokami, Osamu Yokosuka, Tetsuo Takehara, et al.
The Lancet. Infectious Diseases|April 24, 2021
Personalised randomised controlled trial designs-a new paradigm to define optimal treatments for carbapenem-resistant infectionsA Sarah Walker, Ian R White, Rebecca M Turner, et al.
The Lancet. Infectious Diseases|March 17, 2015
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)Marc Bourlière, Jean-Pierre Bronowicki, Victor de Ledinghen, et al.
The Lancet. Infectious Diseases|May 13, 2023
Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trialAmanda L Wilkinson, Khalequ Zaman, Masuma Hoque, et al.
Pageof 270